Heat shock proteins in cardiovascular disease and the prognostic value of heat shock protein related measurements

Heart

Volumn 91, Issue 9, 2005, Pages 1124-1126

  Pockley, A Graham ^a,b   Frostegard J ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 60 ANTIBODY; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 65 ANTIBODY; HEAT SHOCK PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; EDITORIAL; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; VASCULAR DISEASE;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HEAT-SHOCK PROTEINS; HUMANS; PROGNOSIS;

EID: 23944445296     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.059220     Document Type: Editorial

References (40)

1. Birnie DH, Vickers LE, Hillis WS, et al. Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain. Heart 2005;91:1148-53.
2. Pockley AG, Georgiades A, Thulin T, et al. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003;42:235-8.
3. Znu J, Quyyumi AA, Wu H, et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2003;23:1055-9.
4. Hightower LE. Heat shock, stress proteins, chaperones and proteotoxicity. Cell 1991;66:191-7.
5. Frostegård J, Kjellman B, Gidlund M, et al. Induction of heat shock protein in monocytic cells by oxidised low density lipoprotein. Atherosclerosis 1996;121:93-103.
6. Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990;11:129-36.
7. Young RA. Stress proteins and immunology. Ann Rev Immunol 1990;8:401-20.
8. Lamb JR, Bal V, Mendez-Samperio A, et al. Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol 1989;1:191-6.
9. Venner TJ, Gupta RS. Nucleotide sequence of mouse HSP60 (chaperonin, GroEL homolog) cDNA. Biochim Biophys Acta 1990;1087:336-8.
10. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 1993;341:255-9.
11. Birnie DH, Hood S, Holmes E, et al. Anti-heat shock protein 65 titres in acute myocardial infarction. Lancet 1994;344:1443.
12. Hoppichler F, Lechleitner M, Traweger C, et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996;126:333-8.
13. Frostegård J, Lemne C, Andersson B, et al. Association of serum antibodies to heat-shock protein 65 with borderline hypertension. Hypertension 1997;29:40-4.
14. Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998;19:387-94.
15. Xu Q, Kiechl S, Mayr M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Clinical significance determined in a follow-up study. Circulation 1999;100:1169-74.
16. Veres A, Füst G, Smieja M, et al. Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation 2002;106:2775-80.
17. Wick G, Xu Q. Atherosclerosis - an autoimmune disease. Exp Gerontol 1999;34:559-66.
18. Wick G, Perschinka H, Millonig G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol 2001;22:665-9.
19. Schett G, Xu Q, Amberger A, et al. Autoantibodies against heat shock protein mediate endothelial cytotoxicity. J Clin Invest 1995;96:2569-77.
20. Mayr M, Metzler B, Kiechl S, et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumonia. Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999;99:1560-6.
21. Zhu J, Quyyumi AA, Rott D, et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001;103:1071-5.
22. Burian K, Kis Z, Virok D, et al. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001;103:1503-8.
23. Prohászka Z, Duba J, Horváth L, et al. Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest 2001;31:285-92.
24. Veres A, Szamosi T, Ablonczy M, et al. Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease. Eur J Clin Invest 2002;32:405-10.
25. Prohászka Z, Duba J, Lakos G, et al. Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol 1999;11:1363-70.
26. Mahdi OS, Horne BD, Mullen K, et al. Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 2002;106:1659-63.
27. Pockley AG, Shephend J, Corton J. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest 1998;27:367-77.
28. Pockley AG, Bulmer J, Hanks BM, et al. Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 1999;4:29-35.
29. Pockley AG, Wu R, Lemne C, et al. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000;36:303-7.
30. Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000;102:14-20.
31. Pockley AG, de Faire U, Kiessling R, et al. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertension 2002;20:1815-20.
32. Lewthwaite J, Owen N, Coates A, et al. Circulating human heat shock protein 60 in the plasma of British civil servants. Circulation 2002;106:196-201.
33. Hunter-Lavin C, Hudson PR, Mukherjee S, et al. Folate supplementation reduces serum Hsp70 levels in patients with type 2 diabetes. Cell Stress Chaperones 2004;9:344-9.
34. Anderson CF, Lucas M, Gutierrez-Kobeh L, et al. T cell biasing by activated dendritic cells. J Immunol 2004;173:955-61.
35. Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001;104:197-202.
36. Maron R, Sukhova G, Faria A-M, et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002;106:1708-15.
37. Harats D, Yacov N, Gilburd B, et al. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 2002;40:1333-8.
38. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunisation with heat shock protein 65. Arterioscler Thromb 1992;12:789-99.
39. George J, Shoenfeld Y, Afek A, et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein 65. Arterioscler Thromb Vasc Biol 1999;19:505-10.
40. Afek A, George J, Gilburd B, et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (Hsp65) promotes early atherosclerosis. J Autoimmunity 2000;14:115-21.